The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.
[en] The advancement of snakebite therapeutics is imperative due to the substantial morbidity and mortality associated with envenomation. Treatments based on animal-derived antivenoms face limitations in efficacy, safety and cost-effectiveness. To overcome these challenges, the ADDovenom project aims to introduce a groundbreaking snakebite therapy utilizing thermostable protein-based ADDomer nanoparticles. These nanoparticles, derived from the adenovirus penton base protein, provide 60 high avidity binding sites for venom toxins, potentially revolutionizing antivenom development. Through cutting-edge protein engineering, expression technology, and mass spectrometry, alongside venom neutralization assays, the project delineates methodologies to develop next-generation antivenoms with unparalleled efficacy, safety, and affordability.
Disciplines :
Chemistry
Author, co-author :
Redureau, Damien ; Université de Liège - ULiège > Molecular Systems (MolSys)
Language :
English
Title :
Exploring Venomics and Antivenomics in the ADDovenom Project: Advancing Next-Generation Antivenoms based on Virus-Like Particles